MEA Blood Testing Market

Middle East & Africa Blood Testing Market Size (2024 to 2032)

According to the report, the Middle East & Africa Blood Testing Market size is valued at USD 5.95 billion in 2024. It is estimated to be growing at a CAGR of 2.69% to reach USD 7.36 billion by 2032.

Blood testing is a laboratory-based examination performed directly to conclude the general state of health, the occurrence of a bacteria or virus, and to consider disease progression. It is usually performed by taking a small sample of blood from the patient’s body with the help of a needle or finger prick.

A shift in healthcare providers focus from treatment towards early exposure of diseases, particularly in fields of cardiovascular and endocrinology medicine, has poised the industry to observe lucrative growth during the forecast period. Other notable drivers include introducing various innovative solutions that enable faster and accurate diagnosis by using plasma or serum screening methods. Restraints for the market include the high cost of advanced blood culture techniques and the lack of appropriate reimbursement policies.

This research report on the Middle East & Africa Blood Testing Market has been segmented and sub-segmented into the following categories.

• By Type: Complete Blood Count, Blood Chemistry Tests, Blood enzyme tests, Blood Clotting Tests.
• By Disease: Anemia, Infection, Leukemia, Hypokalemia, Kidney Disorders, Heart Attack, Coronary Heart Disease.
• By Method: Manual Blood Culture Testing, Automated Blood Culture Testing.
• By Country: KSA, UAE, Israel, the rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA.

Based on region, Africa is leading the blood testing market, and Middle-East is estimated to grow at the highest CAGR in the forecast period.

In the forecast period, the Middle East is expected with the highest market growth, whereas Africa is already a leading market in Blood testing and screening. On big boom to market growth in this region, the government promotes healthcare and facilities within the limited funds. The aim is to provide excellent hospitality and health, reduce stays in the hospitals, and reduce expenses; the government encourages home treatments. Hence the portable blood testing kits then increased market size on a considerable scale.

Disease-related hospitality expenses and health care are also monitored by various government and non-government organizations in Soviet Central Asia. Blood tests can be carried out most outside clinics, Diagnostic centers, physician’s offices, and more growth and ease for the blood testing market. Alongside blood banking units, blood donation camps, and cancer diagnostics are reported at a high rate in South Africa and Nigeria. The other important factor in the Middle East and African upgrading regions are that the focus shift on the point of care diagnostics. Diagnostic offers rapid diagnosis and results for blood tests such as sugar tests, lipid tests, blood glucose and electrolytes, and coagulation tests.

Key Market Companies leading the Middle East & Africa Blood Testing Market Profiled in the Report are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).